Iron showdown: which infusion works best for anemic Moms-to-Be?

NCT ID NCT07115121

Completed Disease control Sponsor: Muhammad Aamir Latif Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study compared two intravenous iron treatments—ferric carboxymaltose and iron sucrose—in 40 pregnant women with anemia. The goal was to see which one raised hemoglobin levels more. Both are already used in practice, but local data was lacking. The trial is now complete, and results will help guide treatment choices for anemic mothers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Intravenous iron (ferric carboxymaltose or iron sucrose)
What this could lead to: If one iron treatment works better, it could help doctors choose the best option for anemic pregnant women, improving their health and reducing risks.
What could go wrong: This is a small, completed study with only 40 participants. Results may not apply to all pregnant women, and the trial did not track long-term outcomes or side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANEMIA

Contacts and locations

Locations

Bahawal Victoria Hospital

Bahawalpur, Punjab Province, 63100, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.